Antioxidative/oxidative effects and retarding osteoconductivity of ciprofloxacin-loaded porous polyvinyl alcohol/bioactive glass hybrid

被引:8
作者
Boulila, Salha [1 ,6 ,7 ]
Oudadesse, Hassane [1 ]
Badraoui, Riadh [2 ]
Lefeuvre, Bertrand [1 ]
Mabrouk, Mostafa [3 ]
Chaabouni, Khansa [4 ]
Mostafa, Amany [3 ]
Makni-Ayedi, Fatma [4 ]
Barroug, Allal [5 ]
Rebai, Tarek [2 ]
Elfeki, Abdelfattah [6 ]
Elfeki, Hafed [7 ]
机构
[1] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France
[2] Sfax Univ, Fac Med, Lab Histoembryol & Cytogenet, Sfax, Tunisia
[3] NRC, Cairo, Egypt
[4] Univ Hosp Habib Bourguiba, Biochem Lab, Ave El Fardous, Sfax 3029, Tunisia
[5] Univ Cadi Ayyad, Marrakech & CNRST, Rabat, Morocco
[6] Univ Sfax, Fac Sci Sfax, Lab Anim Ecophysiol, POB 95, Sfax 3052, Tunisia
[7] Fac Sci Sfax, Lab Sci Mat & Environm, BP 1171, Sfax 3000, Tunisia
关键词
Bioglass; Ciprofloxacin; Melting; Prooxidant; Retard; DRUG-DELIVERY SYSTEMS; BIOACTIVE GLASS; COMPOSITE SCAFFOLDS; CONTROLLED-RELEASE; IN-VITRO; HYDROXYAPATITE; FLUOROQUINOLONES; INHIBITION; IMPLANTS; CELLS;
D O I
10.1007/s11517-016-1473-1
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
This study investigated the effect of bioglass (melting)-polyvinyl alcohol (BG (M)-PVA) and bioglass (melting)-polyvinyl alcohol-20 %ciprofloxacin (BG(M)-PVA-20Cip) in improving antioxidant activity and regenerating bone capacity. These composites were implanted in femoral condyles of ovariectomized Wistar rats and compared to that of controls groups. After the different period of implantation (15, 30, 60 and 90 days), the treatment of ovariectomized rats with BG(M)-PVA-20Cip showed a significantly higher malondialdehyde concentration when compared to that of BG(M)-PVA group. The superoxide dismutase, glutathione peroxidase and catalase in BG(M)-PVA-20Cip group showed significantly lower activities when compared to those in BG(M)-PVA group. So, BG(M)-PVA is more tolerated by organism than BG(M)-PVA-20Cip. Moreover, the alkaline phosphatase and acid phosphatase activities showed an excellent osteoinductive property of BG (M)-PVA. This property decreased with the presence of ciprofloxacin which is confirmed by histopathological analysis. Several physicochemical techniques showed a rapid reduction in Si and Na in one hand and an accelerator rise in Ca and P ions concentrations in other hand in BG(M)-PVA than in the BG(M)-PVA-20Cip. Therefore, the incorporation of ciprofloxacin in BG(M)-PVA is characterized by a prooxidant effect in oxidant-antioxidant balance at the beginning of treatment and a retard effect of formation of apatitic phase.
引用
收藏
页码:17 / 32
页数:16
相关论文
共 47 条
  • [1] AEBI H, 1984, METHOD ENZYMOL, V105, P121
  • [2] Afolabi OK., 2014, WORLD ACAD SCI ENG T, V8, P72
  • [3] Walker 256/B malignant breast cancer cells disrupt osteoclast cytomorphometry and activity in rats: Modulation by α-tocopherol acetate
    Badraoui, Riadh
    Ben-Nasr, Hmed
    Amamou, Selma
    El-May, Michele Veronique
    Rebai, Tarek
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (03) : 135 - 141
  • [4] Comparison of oxidative stress induced by ciprofloxacin and pyoverdin in bacteria and in leukocytes to evaluate toxicity
    Becerra, MC
    Eraso, AJ
    Albesa, I
    [J]. LUMINESCENCE, 2003, 18 (06) : 334 - 340
  • [5] ASSAYING FOR SUPEROXIDE-DISMUTASE ACTIVITY - SOME LARGE CONSEQUENCES OF MINOR CHANGES IN CONDITIONS
    BEYER, WF
    FRIDOVICH, I
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 161 (02) : 559 - 566
  • [6] Drug delivery systems for intraocular applications
    Bourges, J. -L.
    Touchard, E.
    Kowalczuk, L.
    Berdugo, M.
    Thomas-Doyle, A.
    Bochot, A.
    Gomez, A.
    Azan, F.
    Gurny, R.
    Behar-Cohen, F.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (10): : 1070 - 1088
  • [7] Two-month ciprofloxacin implants for multibacterial bone infections
    Castro, C
    Évora, C
    Baro, M
    Soriano, I
    Sánchez, E
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (03) : 401 - 406
  • [8] Ciprofloxacin implants for bone infection.: In vitro-in vivo characterization
    Castro, C
    Sánchez, E
    Delgado, A
    Soriana, I
    Núñez, P
    Baro, M
    Perera, A
    Évora, C
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 93 (03) : 341 - 354
  • [9] IMPLANTABLE CONTROLLED RELEASE DRUG DELIVERY SYSTEMS - A REVIEW
    DANCKWERTS, M
    FASSIHI, A
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (11) : 1465 - 1502
  • [10] Therapeutic applications of implantable drug delivery systems
    Dash, AK
    Cudworth, GC
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1998, 40 (01) : 1 - 12